Conversations Beyond the Prescription. Where pharma, HCPs, life science and digital health solutions meets patients—after the script is written. Conversations on digital health, engagement, and real-world impacts that are re-writing the future of patient engagement.
The global pharmaceutical landscape is undergoing a dramatic transformation, with UK pharma feeling the squeeze from US pricing reforms and tariff threats. This episode dives deep into how the 2022 U…
The gap between receiving a prescription and achieving successful treatment outcomes remains one of healthcare's biggest challenges. In this illuminating conversation with Ryan Janvion, VP of Sales a…
What happens when the medications patients need simply aren't available? The answer is playing out right now across healthcare systems worldwide as pharmaceutical supply chains face unprecedented pre…
Pharmaceutical manufacturing is undergoing a seismic shift, and Amgen's latest $550 million investment in a cutting-edge biotech research facility in California marks a pivotal moment in this transfo…
Healthcare is undergoing a pricing revolution that will fundamentally transform how pharmaceutical companies connect with patients. The new Most Favored Nation model means Medicare will soon pay no m…
Loneliness isn't merely an emotional challenge—it's a clinical emergency hiding in plain sight. The latest research reveals a startling truth: feeling isolated carries the same health risks as smokin…
The bumpy road to drug pricing reform continues as the US Most Favored Nation deadline of September 29th faces delays. Regulatory complexities, competing healthcare priorities like the Strategic API …
Cathy is the Sr. Director of Product Marketing at Medisafe, driving marketing efforts that make patients the center of digital solutions that make a difference.
PostScripts Rx is not intended to cons…
The pharmaceutical industry faces a transformative shift as drug pricing pressures intensify in the US market, with the September 29 deadline approaching for companies to implement Most Favored Natio…
The clock is ticking for pharmaceutical companies as the September 29 deadline for most favored nation pricing plans looms just 47 days away. This sweeping policy shift represents one of the most sig…
Digital companions are revolutionizing the post-prescription landscape, turning traditional patient support upside down. Cathy Zaremba, Senior Director of Marketing at Medisafe, reveals how personali…
The pharmaceutical landscape is shifting dramatically beneath our feet. With the US government recently demanding drug price reductions of up to 60% from major pharma companies or face potential reim…
The healthcare technology landscape is undergoing a profound transformation with a White House-led initiative dubbed "Make Health Technology Great Again" that aims to create a streamlined approach to…
The healthcare landscape is being reshaped by a powerful new tool: AI voice agents. These conversational companions are addressing one of healthcare's most persistent challenges – medication non-adhe…
Digital health expectations are becoming the new baseline in healthcare as patients increasingly expect the same level of convenience they experience in other aspects of their digital lives. The disc…
What defines truly effective digital health technology in today's healthcare landscape? According to Brian Carr, SVP of Marketing at Medisafe, the answer is refreshingly straightforward: patient enga…
PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment …
A seismic shift may be approaching the pharmaceutical industry with US administration statements suggesting pharmaceutical import tariffs could reach a staggering 250 percent. This isn't just another…